FDA's Undisclosed DTC Ad Letters Target Specific Drug Ads, Websites, Patient Brochures

By Maaisha Osman / September 11, 2025 at 6:23 PM

FDA has launched a two-pronged crackdown on direct-to-consumer advertising, which in addition to broad warning letters to thousands of pharmaceutical companies includes separate yet-to-be-publicized cease-and-desist letters to 100 companies that two people familiar with the matter say target specific products and promotional materials such as TV ads, websites and patient brochures.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.